Bruker Corporation to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 03 2024 - 4:35PM
Business Wire
Bruker Corporation (Nasdaq: BRKR) announced today it will
participate in the 42nd annual J.P. Morgan Healthcare Conference in
San Francisco. Frank Laukien, Chairman, President & CEO, Mark
Munch, Executive Vice President & President of Bruker Nano
Group, and Gerald Herman, Executive Vice President & CFO will
present on behalf of the Company on Monday, January 8th, 2024 at
8:15 AM Pacific Standard Time.
A live audio webcast of the presentation will be available on
the Investor Relations section of the Company's website at
https://ir.bruker.com. A replay of the presentation will be posted
in the “Events & Presentations” section of the Bruker
Corporation Investor Relations website after the event and will be
available for 30 days following the presentation.
About Bruker Corporation (Nasdaq: BRKR)
Bruker is enabling scientists to make breakthrough discoveries
and develop new applications that improve the quality of human
life. Bruker’s high performance scientific instruments and high
value analytical and diagnostic solutions enable scientists to
explore life and materials at molecular, cellular and microscopic
levels. In close cooperation with our customers, Bruker is enabling
innovation, improved productivity and customer success in life
science molecular and cell biology research, in applied and pharma
applications, in microscopy and nanoanalysis, as well as in
industrial applications. Bruker offers differentiated, high-value
life science and diagnostics systems and solutions in preclinical
imaging, clinical phenomics research, proteomics and multiomics,
spatial and single-cell biology, functional structural and
condensate biology, as well as in clinical microbiology and
molecular diagnostics. For more information, please visit:
www.bruker.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240103812532/en/
Justin Ward Sr. Director, Investor Relations & Corporate
Development Bruker Corporation T: +1 (978) 313-5800 E:
Investor.Relations@bruker.com
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Apr 2023 to Apr 2024